Results 121 to 130 of about 3,528,989 (183)

Advances in PSMA-Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer. [PDF]

Cancer Manag Res
Wang J, Yuan H, Xu J, Yang C.
europepmc   +1 more source

Relevance and implementation of patient-specific dosimetry in targeted radionuclide therapy

BIO Web of Conferences, 2019
Bardiès Manuel
doaj   +1 more source

Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]

Int J Mol Sci
Ferro-Flores G, Azorín-Vega E, Ocampo-García B, Luna-Gutiérrez M, Cruz-Nova P, Meléndez-Alafort L.   +5 more
europepmc   +1 more source

Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy. [PDF]

Mol Pharm
Fletcher NL, Houston ZH, Chandler PG, Yan E, Holgate R, Wheatcroft M, Thurecht KJ.   +6 more
europepmc   +1 more source

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Mendes F, Terry SYA, Spiegelberg D, Cornelissen B, Bolcaen J, Nonnekens J, European Working group of Radiobiology of Molecular Radionuclide Therapy.   +6 more
europepmc   +1 more source

Outcome and safety of single-dose docetaxel-augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience. [PDF]

EJNMMI Res
Ebert N, Rosar F, Burgard C, Bartholomä M, Maus S, Hein C, Blickle A, Ezziddin S, Khreish F.   +8 more
europepmc   +1 more source

Tumor sink effect on melanin-ligand [¹³¹I]ICF01012 in melanoma and its implications for targeted radionuclide therapy. [PDF]

EJNMMI Res
Jouberton E, Besse S, Billoux T, Auzeloux P, Schmitt S, Chezal JM, Sas N, Noirault L, Auriol M, Levesque S, Delmas M, Chaussin B, Chautard E, Miot-Noirault E, Rouanet J, Cachin F.   +15 more
europepmc   +1 more source

Dosimetry of alpha-emitting radionuclides for targeted radionuclide therapy

Targeted radionuclide therapy (TRT) is a nuclear medicine-based cancer treatment technique that consists in coupling a radionuclide with a carrier molecule able to specifically target cancer cells. In this context, the radionuclides commonly used in clinic are mainly β− emitters (177Lu, 131I, 90Y), although an α-emitter (223Ra) has been recently ...
openaire   +2 more sources

Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade. [PDF]

Front Nucl Med
Haugh KN, Sanwick AM, Chaple IF.
europepmc   +1 more source

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. [PDF]

Neuro Oncol
Weller M, Albert NL, Galldiks N, Bink A, Preusser M, Sulman EP, Treyer V, Wen PY, Tonn JC, Le Rhun E.   +9 more
europepmc   +1 more source